PHARMACOLOGICAL ACTIVATION OF PP2A AS A NOVEL TREATMENT APPROACH FOR PULMONARY FIBROSIS

$199,586FY2020Defense Health AgencyDOD

Atux Iskay Group Llc, Plainsboro NJ

Investigators